Current Progress in Treating Systemic Lupus Erythematosus Using Exosomes/MicroRNAs
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease associated with impaired organ functions that can seriously affect the daily life of patients. Recent SLE therapies frequently elicit adverse reactions and side effects in patients, and clinical heterogeneity is considerable...
Main Authors: | Yi-jing Liu, Hai-bing Miao, Shu Lin, Zhen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-01-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/09636897221148775 |
Similar Items
-
Circulating exosomal microRNAs as biomarkers of lupus nephritis
by: Fei Chen, et al.
Published: (2023-12-01) -
Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus
by: Barbara Stypińska, et al.
Published: (2015-10-01) -
Progress on the correlation between exosomal microRNAs and Alzheimer's disease
by: DIAO Hua-qiong, LI Xiao-li, LIN Liang-yin, LIU Hai-peng, CHEN Hong-jing, DING Hai-yue, WEI Dan
Published: (2020-11-01) -
Research progress on exosomes/microRNAs in the treatment of diabetic retinopathy
by: Si-ru Niu, et al.
Published: (2022-08-01) -
Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
by: Xiaoyan Qi, et al.
Published: (2022-11-01)